Recruiting Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma NCT05603910 Conditions Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more Locations University of Miami — Miami, Florida, United States View Trial Details
Recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381 Conditions Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more Locations Mayo Clinic in Florida — Jacksonville, Florida, United States View Trial Details
Active, Not Recruiting Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial NCT04704661 Conditions Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more Locations UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California, United States Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California, United States View all 23 locations View more locations Show fewer locations Loading locations... View Trial Details
